(Q33926003)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Engineered nanomedicine for myeloma and bone microenvironment targeting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Pamela A Basto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Nazila Kamaly

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Nicolas Bertrand

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Antonio Sacco

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Aldo M Roccaro

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Omid C. Farokhzad

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

6

Siobhan Glavey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

4

Yuji Mishima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

8

Michele Moschetta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

14

Salomon Manier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

23

Irene M Ghobrial

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

12

Masoumeh Memarzadeh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

18

Kenichi Nagano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

15

Jinjun Shi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1

Archana Swami

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Sufeng Zhang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Dushanth Seevaratnam

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yong Zhang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Jinhe Liu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Jun Wu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Zhi Ning Lu

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Roland Baron

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

English

0 references

publication date

30 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

Proceedings of the National Academy of Sciences of the United States of America

21 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

10287-10292

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery

21 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138(-) CD34(-) tumor stem-like cells in multiple myeloma-bearing mice

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Silica nanoparticles sensitize human multiple myeloma cells to snake (Walterinnesia aegyptia) venom-induced apoptosis and growth arrest

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Modulation of eIF5A expression using SNS01 nanoparticles inhibits NF-κB activity and tumor growth in murine models of multiple myeloma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Characterization and cytotoxicity of self-organized assemblies of curcumin and amphiphatic poly(ethylene glycol).

28 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

28 July 2018

https://api.crossref.org/works/10.1073%2FPNAS.1401337111

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Therapy with bortezomib plus dexamethasone induces osteoblast activation in responsive patients with multiple myeloma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104924

Pathogenesis of myeloma bone disease

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1401337111

Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1401337111

Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1401337111

Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24982170

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24982170

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.1401337111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24982170%20AND%20SRC:MED&resulttype=core&format=json